| 000 | 04677cam a2200661Ii 4500 | ||
|---|---|---|---|
| 001 | ocn999588293 | ||
| 005 | 20250919141839.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 170804s2017 gw ob 001 0 eng d | ||
| 020 |
_a9783527699131 _q(electronic bk.) |
||
| 020 |
_a3527699139 _q(electronic bk.) |
||
| 020 |
_a9783527699124 _q(electronic bk.) |
||
| 020 |
_a3527699120 _q(electronic bk.) |
||
| 020 | _z3527340866 | ||
| 020 | _z9783527340866 | ||
| 029 | 1 |
_aCHVBK _b495227986 |
|
| 029 | 1 |
_aCHNEW _b000964933 |
|
| 029 | 1 |
_aDEBSZ _b494212101 |
|
| 035 |
_a(OCoLC)999588293 _z(OCoLC)998785567 _z(OCoLC)1000037842 _z(OCoLC)1002125199 |
||
| 040 |
_aYDX _beng _cYDX _dNST _dIDEBK _dEBLCP _dNLE _dOCLCO _dDG1 _dOCLCQ _dNST _dRECBK _dOCLCF _dUAB _dUPM _dDEBSZ |
||
| 049 | _aMAIN | ||
| 050 | 4 | _aRM666.P87 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615.3 _223 |
| 245 | 0 | 0 |
_aProtein therapeutics _h[electronic resource] / _cedited by Tristan Vaughan, Jane Osbourn, and Bahija Jallal. |
| 260 |
_aWeinheim, Germany : _bWiley-VCH, _c[2017] |
||
| 300 | _a1 online resource. | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 |
_aMethods and principles in medicinal chemistry ; _vv. 71 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | _aIn this practice-oriented two volume handbook, professionals from some of the largest biopharmaceutical companies and top academic researchers address the key concepts and challenges in the development of protein pharmaceuticals for medicinal chemists and drug developers of all trades. Following an introduction tracing the rapid development of the protein therapeutics market over the last decade, all currently used therapeutic protein scaffolds are surveyed, from human and non-human antibodies to antibody mimetics, bispecific antibodies and antibody-drug conjugates. This ready reference then goes on to review other key aspects such as pharmacokinetics, safety and immunogenicity, manufacture, formulation and delivery. The handbook then takes a look at current key clinical applications for protein therapeutics, from respiratory and inflammation to oncology and immune-oncology, infectious diseases and rescue therapy. Finally, several exciting prospects for the future of protein therapeutics are highlighted and discussed. | ||
| 505 | 0 | _aCover ; Title Page ; Copyright ; Contents; Preface ; A Personal Foreword ; Acknowledgments ; Volume 1; Part I Introduction to Protein Therapeutics: Past and Present ; Chapter 1 Early Recombinant Protein Therapeutics ; 1.1 Introduction ; 1.2 The Birth of Genetic Engineering | |
| 505 | 8 | _a1.3 Recombinant Human Insulin 1.3.1 The Race to Clone the Human Insulin Gene and to Produce Human Recombinant Insulin ; 1.3.2 Novo's Counter Strategy: Semisynthetic Human Insulin ; 1.3.3 Yeast Recombinant Insulin ; 1.4 Recombinant Human Growth Hormone ; 1.5 Recombinant Human Interferons | |
| 505 | 8 | _a1.6 Recombinant Human Erythropoietin 1.7 Recombinant Tissue -- Type Plasminogen Activator ; 1.8 Recombinant Hepatitis B Virus (HBV) Vaccine ; 1.9 Postscript ; Acknowledgments ; References ; Chapter 2 Evolution of Antibody Therapeutics | |
| 505 | 8 | _a2.1 Overview of Antibody Therapeutics Development 2.2 Polyclonal Antibodies -- Laying the Foundation for mAb Therapy ; 2.3 Evolution of Monoclonal Antibody Therapeutics ; 2.3.1 Chimeric and Humanized mAbs ; 2.3.2 Fully Human Antibodies ; 2.4 Fc Fusion Proteins | |
| 505 | 8 | _a2.5 Evolution of Concepts in Antibody Pharmacology 2.5.1 Neutralization ; 2.5.2 From Killing Bacteria to Killing Human Cells ; 2.5.3 Targeting Membrane Receptors ; 2.6 Future Directions for Antibody Therapeutics Development ; Acknowledgments ; References | |
| 650 | 0 | _aProtein drugs. | |
| 650 | 0 |
_aProteins _xTherapeutic use. |
|
| 650 | 7 |
_aMEDICAL / Pharmacology _2bisacsh |
|
| 650 | 7 |
_aProtein drugs. _2fast _0(OCoLC)fst01079679 |
|
| 650 | 7 |
_aProteins _xTherapeutic use. _2fast _0(OCoLC)fst01079767 |
|
| 655 | 4 | _aElectronic books. | |
| 655 | 0 | _aElectronic books. | |
| 700 | 1 |
_aVaughan, Tristan, _eeditor. |
|
| 700 | 1 |
_aOsbourn, Jane, _eeditor. |
|
| 700 | 1 |
_aJallal, Bahija, _eeditor. |
|
| 776 | 0 | 8 |
_cOriginal _z3527340866 _z9783527340866 _w(OCoLC)988760633 |
| 830 | 0 |
_aMethods and principles in medicinal chemistry ; _vv. 71. |
|
| 856 | 4 | 0 |
_uhttps://eresourcesptsl.ukm.remotexs.co/user/login?url=https://doi.org/10.1002/9783527699124 _zWiley Online Library |
| 907 |
_a.b16816699 _b2022-11-02 _c2020-07-17 |
||
| 942 | _n0 | ||
| 998 |
_ae _b2020-07-17 _cm _dz _feng _ggw _y0 _z.b16816699 |
||
| 999 |
_c649078 _d649078 |
||